BR0009551A - Pharmaceutical suspension for drinking - Google Patents
Pharmaceutical suspension for drinkingInfo
- Publication number
- BR0009551A BR0009551A BR0009551-6A BR0009551A BR0009551A BR 0009551 A BR0009551 A BR 0009551A BR 0009551 A BR0009551 A BR 0009551A BR 0009551 A BR0009551 A BR 0009551A
- Authority
- BR
- Brazil
- Prior art keywords
- drinking
- pharmaceutical suspension
- suspension
- pharmaceutical
- weight
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/04—Amoebicides
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Rheumatology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Emergency Medicine (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
"SUSPENSãO FARMACêUTICA PARA BEBER". Esta invenção refere-se a uma suspensão farmacêutica para beber em que a fração solúvel do ou dos princípios ativos que ela contém é inferior a 1 0% em peso em relação ao peso da suspensão."PHARMACEUTICAL SUSPENSION TO DRINK". This invention relates to a pharmaceutical suspension for drinking in which the soluble fraction of the active ingredient (s) it contains is less than 10% by weight relative to the weight of the suspension.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9904251A FR2791888B1 (en) | 1999-04-06 | 1999-04-06 | ORAL PHARMACEUTICAL SUSPENSION |
PCT/FR2000/000870 WO2000059468A1 (en) | 1999-04-06 | 2000-04-06 | Drinkable pharmaceutical solution |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0009551A true BR0009551A (en) | 2002-05-28 |
Family
ID=9544041
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0009551-6A BR0009551A (en) | 1999-04-06 | 2000-04-06 | Pharmaceutical suspension for drinking |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP1165043A1 (en) |
CN (1) | CN1351488A (en) |
AU (1) | AU778364B2 (en) |
BR (1) | BR0009551A (en) |
FR (1) | FR2791888B1 (en) |
HU (1) | HUP0200711A3 (en) |
IL (1) | IL145768A0 (en) |
WO (1) | WO2000059468A1 (en) |
ZA (2) | ZA200108116B (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2323264T3 (en) * | 2001-08-01 | 2009-07-10 | Novartis Ag | COMPOSITION FOR MASK OF FLAVOR. |
US7300670B2 (en) * | 2002-04-03 | 2007-11-27 | Unilab Pharmatech, Ltd. | Oral suspension formulation |
KR20190026962A (en) | 2014-09-05 | 2019-03-13 | 심바이오믹스 세러퓨틱스 엘엘씨 | Secnidazole for use in the treatment of bacterial vaginosis |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ210785A (en) * | 1984-01-13 | 1987-11-27 | Battelle Development Corp | Liquid dispersions of layered controlled release dosage forms |
DE3900811A1 (en) * | 1989-01-13 | 1990-07-19 | Kali Chemie Pharma Gmbh | NEW MEDICINE |
IE902829A1 (en) * | 1989-08-14 | 1991-02-27 | Eurand America | Microencapsulated taste-masked water-insoluble nsaid drug¹materials |
IL104093A (en) * | 1991-12-31 | 1999-06-20 | Abbott Lab | Prolamine coatings for taste-masking orally administrable medicaments |
BR9505962A (en) * | 1994-12-21 | 1997-12-23 | Johnson & Johnson | Aqueous pharmaceutical suspension and process for its preparation |
JPH11504940A (en) * | 1995-05-09 | 1999-05-11 | ザ、プロクター、エンド、ギャンブル、カンパニー | Bismuth and one or more antimicrobial-containing compositions for the treatment and prevention of gastrointestinal disorders |
-
1999
- 1999-04-06 FR FR9904251A patent/FR2791888B1/en not_active Expired - Fee Related
-
2000
- 2000-04-06 WO PCT/FR2000/000870 patent/WO2000059468A1/en not_active Application Discontinuation
- 2000-04-06 CN CN00807589A patent/CN1351488A/en active Pending
- 2000-04-06 HU HU0200711A patent/HUP0200711A3/en unknown
- 2000-04-06 BR BR0009551-6A patent/BR0009551A/en not_active IP Right Cessation
- 2000-04-06 AU AU38252/00A patent/AU778364B2/en not_active Ceased
- 2000-04-06 IL IL14576800A patent/IL145768A0/en unknown
- 2000-04-06 EP EP00917140A patent/EP1165043A1/en not_active Withdrawn
-
2001
- 2001-10-03 ZA ZA200108116A patent/ZA200108116B/en unknown
- 2001-10-05 ZA ZA200108206A patent/ZA200108206B/en unknown
Also Published As
Publication number | Publication date |
---|---|
FR2791888B1 (en) | 2004-10-08 |
WO2000059468A1 (en) | 2000-10-12 |
HUP0200711A3 (en) | 2003-04-28 |
IL145768A0 (en) | 2002-07-25 |
AU3825200A (en) | 2000-10-23 |
AU778364B2 (en) | 2004-12-02 |
FR2791888A1 (en) | 2000-10-13 |
EP1165043A1 (en) | 2002-01-02 |
HUP0200711A2 (en) | 2002-07-29 |
ZA200108116B (en) | 2002-09-25 |
ZA200108206B (en) | 2002-12-24 |
CN1351488A (en) | 2002-05-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0212986A (en) | Imizadol-4-carboxamide derivatives, preparation and use for obesity treatment | |
TR200003735T2 (en) | Prevention and treatment of disorders related to osteoporosis and menopause syndrome | |
BR0013777A (en) | Compounds, formulations, beverages, foodstuffs and therapeutic uses that involve or serve to prepare isoflavone compounds and their analogs | |
BR9711805A (en) | Compounds and methods for providing pharmacologically active preparations and use | |
BR0115411A (en) | Synergistic combinations comprising a renin inhibitor for cardiovascular diseases. | |
BRPI0316532B8 (en) | pharmaceutical compositions comprising a basic or acidic drug, a surfactant, and a physiologically tolerable water-soluble acid or base | |
BR0109966A (en) | Combination of Organic Compounds | |
ECSP067043A (en) | USEFUL PIRROLOTRIAZINE DERIVATIVES TO TREAT HYPER-PROLIFERATIVE DISORDERS AND DISEASES ASSOCIATED WITH ANGIOGENESIS | |
BR0007556A (en) | Tweak and tweak receptor antagonists and their use to treat immune disorders | |
BR0203172A (en) | Therapeutic Agents for Achondroplasia | |
BRPI0416752A (en) | pharmaceutical composition, use of one or more compounds, method for the prevention or treatment of disorders, compounds, and process for the preparation of a pharmaceutical composition | |
BRPI9809468B8 (en) | Pharmaceutical formulations containing voriconazole | |
ITRM990338A0 (en) | DIETARY OR PHARMACEUTICAL COMPOSITION USEFUL FOR THE PREVENTION OR TREATMENT OF HYPEROXALURIA. | |
PT1328268E (en) | COMBINATION OF CATHETER AND QUERCETINE FOR PHARMACEUTICAL OR DIETETIC USE | |
BR0009594A (en) | Compound derived from amine or a pharmacologically acceptable salt thereof, drug, insulin tolerance enhancing agent, blood sugar lowering agent, immunoregulatory agent, aldose reductase inhibiting agent, 5-lipoxygenase inhibiting agent, formation inhibiting agent lipid peroxide, ppar activating agent, antiosteoporosis agent, leukotriene antagonist agent, fat cell promoting agent, cancer cell proliferation inhibiting agent or calcium antagonist agent, pharmaceutical composition and use of a compound | |
FR2857596B1 (en) | USE OF A COSMETIC OR PHARMACEUTICAL COMPOSITION COMPRISING A LUPEOL-RICH EXTRACT AS AN ACTIVE INGREDIENT TO STIMULATE THE SYNTHESIS OF STRESS PROTEINS | |
MA29723B1 (en) | COMPOUNDS | |
NO20000310D0 (en) | Pharmaceutical compositions containing vitamin D and calcium, their preparation and therapeutic use | |
BR0013009A (en) | Use of cgrp antagonists and cgrp release inhibitors to combat menopausal hot jets | |
BR0015540A (en) | Adenosine receptor antagonists and methods of preparing and using them | |
EP1032556A4 (en) | Pharmaceutically active compounds and methods of use | |
EP1736470A3 (en) | Pyrimidine derivatives as CB2 cannabinoid receptor modulators | |
BR0009551A (en) | Pharmaceutical suspension for drinking | |
WO2000054780A3 (en) | Corticosteroid formulation | |
BR0014598A (en) | Synergistic combinations of an nk receptor antagonist, and a gaba structural analog |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 6A, 7A E 8A ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 1962 DE 12/08/2008. |